|
1
|
Castro C, Peleteiro B, Bento MJ and Lunet
N: Trends in gastric and esophageal cancer incidence in northern
Portugal (1994–2009) by subsite and histology and predictions for
2015. Tumori. 103:155–163. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Leylabadlo HE, Kafil HS and Yousefi M:
Gastric cancer mortality in a high-incidence area (Ardabil
Province, Northwest Iran): What risk factors are causative? Eur J
Cancer Prev. 25:573–574. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yoon SB, Park JM, Lim CH, Kim JS, Cho YK,
Lee BI, Lee IS, Kim SW and Choi MG: Incidence of gastric cancer
after endoscopic resection of gastric adenoma. Gastrointest Endosc.
83:1176–1183. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nicolas C, Sylvain M, Come L, Jean F,
Anne-Marie B and Valerie J: Trends in gastric cancer incidence: A
period and birth cohort analysis in a well-defined French
population. Gastric Cancer. 19:508–514. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu H, Cai Z, Lu G, Cao S, Huang H, Jiang Y
and Sun W: Impact of c-erbB-2 protein on 5-year survival rate of
gastric cancer patients after surgery: A cohort study and
meta-analysis. Tumori. 103:249–254. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Greenhill C: Gastric cancer. Metformin
improves survival and recurrence rate in patients with diabetes and
gastric cancer. Nat Rev Gastroenterol Hepatol. 12:1242015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xie R, Wang X, Qi G, Wu Z, Wei R, Li P and
Zhang D: DDR1 enhances invasion and metastasis of gastric cancer
via epithelial-mesenchymal transition. Tumour Biol. 37:12049–12059.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Deng QJ, Xie LQ and Li H: Overexpressed
MALAT1 promotes invasion and metastasis of gastric cancer cells via
increasing EGFL7 expression. Life Sci. 157:38–44. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ara H, Takagishi M, Enomoto A, Asai M,
Ushida K, Asai N, Shimoyama Y, Kaibuchi K, Kodera Y and Takahashi
M: Role for Daple in non-canonical Wnt signaling during gastric
cancer invasion and metastasis. Cancer Sci. 107:133–139. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Armas P, Margarit E, Mouguelar VS, Allende
ML and Calcaterra NB: Beyond the binding site: In vivo
identification of tbx2, smarca5 and wnt5b as molecular targets of
CNBP during embryonic development. PLoS One. 8:e632342013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Miskolczi-McCallum CM, Scavetta RJ,
Svendsen PC, Soanes KH and Brook WJ: The Drosophila melanogaster
T-box genes midline and H15 are conserved regulators of heart
development. Dev Biol. 278:459–472. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Takabatake Y, Takabatake T, Sasagawa S and
Takeshima K: Conserved expression control and shared activity
between cognate T-box genes TBX2 and Tbx3 in connection with Sonic
hedgehog signaling during Xenopus eye development. Dev Growth
Differ. 44:257–271. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Takabatake Y, Takabatake T and Takeshima
K: Conserved and divergent expression of T-box genes TBX2-Tbx5 in
Xenopus. Mech Dev. 91:433–437. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Papaioannou VE: The T-box gene family:
Emerging roles in development, stem cells and cancer. Development.
141:3819–3833. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Takahashi H: Functional evolution of T-box
gene family on animal development. Tanpakushitsu Kakusan Koso.
46:1349–1357. 2001.(In Japanese). PubMed/NCBI
|
|
16
|
Papaioannou VE and Silver LM: The T-box
gene family. Bioessays. 20:9–19. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yi CH, Terrett JA, Li QY, Ellington K,
Packham EA, Armstrong-Buisseret L, McClure P, Slingsby T and Brook
JD: Identification, mapping and phylogenomic analysis of four new
human members of the T-box gene family: EOMES, TBX6, TBX18 and
TBX19. Genomics. 55:10–20. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Brend T and Holley SA: Expression of the
oscillating gene her1 is directly regulated by Hairy/Enhancer of
Split, T-box and Suppressor of Hairless proteins in the zebrafish
segmentation clock. Dev Dyn. 238:2745–2759. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Butz NV, Gronostajski RM and Campbell CE:
T-box proteins differentially activate the expression of the
endogenous interferon gamma gene versus transfected reporter genes
in non-immune cells. Gene. 377:130–139. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wan Z, Jiang D, Chen S, Jiao J, Ji L, Shah
AS, Wei H, Yang X, Li X, Wang Y and Xiao J: T-box transcription
factor brachyury promotes tumor cell invasion and metastasis in
non-small cell lung cancer via upregulation of matrix
metalloproteinase 12. Oncol Rep. 36:306–314. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu H, Liu BO, Liu A, Li K and Zhao H:
T-box 2 expression predicts poor prognosis in gastric cancer. Oncol
Lett. 10:1689–1693. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen S, Jiao J, Jiang D, Wan Z, Li L, Li
K, Xu L, Zhou Z, Xu W and Xiao J: T-box transcription factor
Brachyury in lung cancer cells inhibits macrophage infiltration by
suppressing CCL2 and CCL4 chemokines. Tumour Biol. 36:5881–5890.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Abrahams A, Parker MI and Prince S: The
T-box transcription factor TBX2: Its role in development and
possible implication in cancer. IUBMB Life. 62:92–102.
2010.PubMed/NCBI
|
|
24
|
Douglas NC and Papaioannou VE: The T-box
transcription factors TBX2 and TBX3 in mammary gland development
and breast cancer. J Mammary Gland Biol Neoplasia. 18:143–147.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Boskovic G and Niles RM: T-box binding
protein type two (TBX2) is an immediate early gene target in
retinoic-acid-treated B16 murine melanoma cells. Exp Cell Res.
295:281–289. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu WK, Jiang XY and Zhang ZX: Expression
of PSCA, PIWIL1 and TBX2 in endometrial adenocarcinoma. Onkologie.
33:241–245. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu WK, Jiang XY and Zhang ZX: Expression
of PSCA, PIWIL1 and TBX2 and its correlation with HPV16 infection
in formalin-fixed, paraffin-embedded cervical squamous cell
carcinoma specimens. Arch Virol. 157:657–663. 2010. View Article : Google Scholar
|
|
28
|
Han Y, Tu WW, Wen YG, Yan DW, Qiu GQ, Peng
ZH and Zhou CZ: Increased expression of TBX2 is a novel independent
prognostic biomarker of a worse outcome in colorectal cancer
patients after curative surgery and a potential therapeutic target.
Med Oncol. 30:6882013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Duo S, Tiao-Dong T, Lei Z, Wei W, Hong-Li
S and Xian-Wei D: Expression and clinical significance of tbx2 in
pancreatic cancer. Asian Pac J Cancer Prev. 10:118–122.
2009.PubMed/NCBI
|
|
30
|
Ludtke TH, Farin HF, Rudat C,
Schuster-Gossler K, Petry M, Barnett P, Christoffels VM and Kispert
A: TBX2 controls lung growth by direct repression of the cell cycle
inhibitor genes Cdkn1a and Cdkn1b. PLoS Genet. 9:e10031892013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bilican B and Goding CR: Cell cycle
regulation of the T-box transcription factor tbx2. Exp Cell Res.
312:2358–2366. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Figueira RC, Gomes LR, Neto JS, Silva FC,
Silva ID and Sogayar MC: Correlation between MMPs and their
inhibitors in breast cancer tumor tissue specimens and in cell
lines with different metastatic potential. BMC Cancer. 9:202009.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nutt JE, Durkan GC, Mellon JK and Lunec J:
Matrix metalloproteinases (MMPs) in bladder cancer: The induction
of MMP9 by epidermal growth factor and its detection in urine. BJU
Int. 91:99–104. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bachmeier BE, Nerlich AG, Lichtinghagen R
and Sommerhoff CP: Matrix metalloproteinases (MMPs) in breast
cancer cell lines of different tumorigenicity. Anticancer Res.
21:3821–3828. 2001.PubMed/NCBI
|
|
35
|
Roh MR, Zheng Z, Kim HS, Kwon JE, Jeung
HC, Rha SY and Chung KY: Differential expression patterns of MMPs
and their role in the invasion of epithelial premalignant tumors
and invasive cutaneous squamous cell carcinoma. Exp Mol Pathol.
92:236–242. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jung SA, Yang SK, Kim JS, Shim KN, Im SA,
Myung SJ, Jung HY, Yu CS, Kim JC, Hong WS, et al: The expression of
matrix metalloproteinases (MMPs), tissue inhibitor of
metalloproteinases (TIMPs) and angiogenesis in relation to the
depth of tumor invasion and lymph node metastasis in submucosally
invasive colorectal carcinoma. Korean J Gastroenterol. 45:401–408.
2005.(In Korean). PubMed/NCBI
|
|
37
|
Hotary KB, Yana I, Sabeh F, Li XY,
Holmbeck K, Birkedal-Hansen H, Allen ED, Hiraoka N and Weiss SJ:
Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity
via MT1-MMP-dependent and -independent processes. J Exp Med.
195:295–308. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Matos ML, Lapyckyj L, Rosso M, Besso MJ,
Mencucci MV, Briggiler CI, Giustina S, Furlong LI and Vazquez-Levin
MH: Identification of a Novel Human E-cadherin splice variant and
assessment of its effects upon EMT-related events. J Cell Physiol.
232:1368–1386. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rogers CD, Saxena A and Bronner ME: Sip1
mediates an E-cadherin-to-N-cadherin switch during cranial neural
crest EMT. J Cell Biol. 203:835–847. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Prince S, Carreira S, Vance KW, Abrahams A
and Goding CR: TBX2 directly represses the expression of the p21
(WAF1) cyclin-dependent kinase inhibitor. Cancer Res. 64:1669–1674.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Huang Y, Li Z, Zhong Q, Li G, Zhang Y and
Huang Z: Association of TBX2 and P21 expression with
clinicopathological features and survival of laryngeal squamous
cell carcinoma. Int J Clin Exp Med. 7:5394–5402. 2014.PubMed/NCBI
|
|
42
|
Zheng X, Wang Y, Liu B, Liu C, Liu D, Zhu
J, Yang C, Yan J, Liao X, Meng X and Yang H: Bmi-1-shRNA inhibits
the proliferation of lung adenocarcinoma cells by blocking the G1/S
phase through decreasing cyclin D1 and increasing p21/p27 levels.
Nucleic Acid Ther. 24:210–216. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bartkova J, Lukas J, Strauss M and Bartek
J: Cyclin D3: Requirement for G1/S transition and high abundance in
quiescent tissues suggest a dual role in proliferation and
differentiation. Oncogene. 17:1027–1037. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chen JR, Chatterjee B, Meyer R, Yu JC,
Borke JL, Isales CM, Kirby ML, Lo CW and Bollag RJ: TBX2 represses
expression of Connexin43 in osteoblastic-like cells. Calcif Tissue
Int. 74:561–573. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
D'Costa ZC, Higgins C, Ong CW, Irwin GW,
Boyle D, McArt DG, McCloskey K, Buckley NE, Crawford NT,
Thiagarajan L, et al: TBX2 represses CST6 resulting in uncontrolled
legumain activity to sustain breast cancer proliferation: A novel
cancer-selective target pathway with therapeutic opportunities.
Oncotarget. 5:1609–1620. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Nandana S, Tripathi M, Duan P, Chu CY,
Mishra R, Liu C, Jin R, Yamashita H, Zayzafoon M, Bhowmick NA, et
al: Bone metastasis of prostate cancer can be therapeutically
targeted at the TBX2-WNT signaling axis. Cancer Res. 77:1331–1344.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ma JW, Zhang Y, Ye JC, Li R, Wen YL, Huang
JX and Zhong XY: Tetrandrine exerts a radiosensitization effect on
human glioma through inhibiting proliferation by attenuating ERK
phosphorylation. Biomol Ther (Seoul). 25:186–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Selvaraj P, Xiao L, Lee C, Murthy SR,
Cawley NX, Lane M, Merchenthaler I, Ahn S and Loh YP: Neurotrophic
Factor-α1: A key wnt-β-catenin dependent anti-proliferation factor
and ERK-Sox9 activated inducer of embryonic neural stem cell
differentiation to astrocytes in neurodevelopment. Stem Cells.
35:557–571. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Liu X, Tian S, Liu M, Jian L and Zhao L:
Wogonin inhibits the proliferation and invasion and induces the
apoptosis of HepG2 and Bel7402 HCC cells through NFκB/Bcl-2, EGFR
and EGFR downstream ERK/AKT signaling. Int J Mol Med. 38:1250–1256.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hamaoka Y, Negishi M and Katoh H: EphA2 is
a key effector of the MEK/ERK/RSK pathway regulating glioblastoma
cell proliferation. Cell Signal. 28:937–945. 2016. View Article : Google Scholar : PubMed/NCBI
|
